Disease | buerger disease |
Comorbidity | C0022116|ischemia |
Sentences | 7 |
PubMedID- 22285343 | Background: to present our experience of extended endovascular management for thromboangiitis obliterans (buerger's disease) patients with critical limb ischemia (cli). |
PubMedID- 21427651 | Conclusion: hepatocyte growth factor gene therapy is safe and effective for critical limb ischemia in patients with buerger's disease. |
PubMedID- 20471787 | By our very limited experience, venous arterialization may be ineffective on improving lower limb ischemia with buerger's disease. |
PubMedID- 25547258 | However, critical hand ischemia in buerger's disease patients has been underappreciated despite a tremendous advancement of endovascular therapy for peripheral arterial disease. |
PubMedID- 20559539 | Colon ischemia associated with buerger's disease: case report and review of the literature. |
PubMedID- 24845736 | Methods: a retrospective review of 103 patients with critical limb ischemia who were diagnosed with buerger's disease by shionoya's criteria between 1980 and 2010. |
PubMedID- 26286269 | Renal failure and mesenteric ischemia associated with thromboangiitis obliterans progression was diagnosed. |
Page: 1